In recent years, the number of targeted cancer drugs has continued to rise. However, conventional chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic agents that attack and kill cancer cells. But these agents also damage healthy t ... more
Dr. Felix Kurth
Eidgenössische Technische Hochschule Zürich (ETH Zürich), Departement Biosysteme
Felix Kurth studied bioengineering at the Technical University Dortmund (Germany) and at the Royal Institute of Technology in Stockholm (Sweden). During his PhD studies at ETH Zurich (Switzerland), which he completed in 2015, he developed lab-on-a-chip systems and methods for quantifying mechanobiological responses at the single-cell level, particularly the characterization of mechanosensitive cation channels. His current research focuses on the implementation of mechanosensitive transmembrane protein complexes in artificial cellular structures.